US SB2064

Requires Medicaid and CHIP (Children's Health Insurance Program) to cover comprehensive tobacco cessation services, including diagnostic, therapy, counseling services, and both prescription and nonprescription FDA-approved cessation medications

Provides a temporary enhanced Federal Medical Assistance Percentage (FMAP) of 90% for tobacco cessation services and related outreach campaigns for a 5-year period beginning upon enactment

Prohibits states from imposing cost-sharing requirements (deductibles, coinsurance, copays) on tobacco cessation services and related prescription drugs under Medicaid and CHIP

Eliminates prior authorization requirements for tobacco cessation drugs under both Medicaid and CHIP state plans

Mandates states monitor and promote tobacco cessation services through outreach campaigns targeting eligible individuals who use tobacco and the clinicians who serve them